The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
The treatment of locally advanced rectal cancer (LARC) has evolved during the last decades, but recurrence remains a problem. Circulating tumor DNA (ctDNA) may result in an individualized treatment approach with improved survival and quality of life, but diverging results impede further development....
Main Authors: | Edina Dizdarevic, Torben Frøstrup Hansen, Anders Jakobsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/9/2252 |
Similar Items
-
Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples
by: Josep Gumà, et al.
Published: (2022-11-01) -
The Role of ctDNA in Gastric Cancer
by: Justin Mencel, et al.
Published: (2022-10-01) -
Role of ctDNA in Breast Cancer
by: Marta Sant, et al.
Published: (2022-01-01) -
CTC, ctDNA, and Exosome in Thyroid Cancers: A Review
by: Wenwen Wang, et al.
Published: (2023-09-01) -
Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
by: Xiaoling Wang, et al.
Published: (2024-01-01)